Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rayomand Press

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Frontiers in Neurology|February 28, 2018
Microangiopathy-A Potential Contributing Factor to Idiopathic Polyneuropathy: A Mini ReviewKristin Samuelsson, Rayomand Press
Lakartidningen|April 21, 2010
[Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far]Rayomand Press, Oluf Andersen
Current Opinion in Neurology|August 11, 2020
Chronic axonal idiopathic polyneuropathy: is it really benignKristin Samuelsson, Rayomand Press
Lakartidningen|June 28, 2012
[Inflammatory polyneuropathies can be treated successfully]Rayomand Press, Håkan Askmark, Oluf Andersen
Journal of the Neurological Sciences|December 3, 2014
Sensory ataxia associated with Graves' diseaseKristin Samuelsson, Mats Palmer, Rayomand Press
Disability and Rehabilitation|November 27, 2008
Disability and health status in patients with chronic inflammatory demyelinating polyneuropathyMimmi Eriksson Westblad, Anette Forsberg, Rayomand Press
Journal of the Neurological Sciences|March 20, 2012
Residual disability 10 years after falling ill in Guillain-Barré syndrome: a prospective follow-up studyAnette Forsberg, Rayomand Press, Lotta Widén Holmqvist
Neurology|February 13, 2002
Non-T(H)1 cytokines are augmented systematically early in Guillain-Barré syndromeRayomand Press, V Ozenci, M Kouwenhoven, et al.
Lakartidningen|March 26, 2025
[Pan-neurofascin autoimmune nodopathy - an emerging and treatable differential diagnosis to Guillain-Barré syndrome]Ivan Kmezic, Anders Eriksson, Eva Sundman, et al.
Journal of the Neurological Sciences|March 6, 2025
Beta-trace protein in chronic inflammatory demyelinating polyradiculoneuropathy and Guillain-Barré syndrome - clinical utilization and a new insight into pathophysiological mechanismsIvan Kmezic, Rasmus Gustafsson, Magnus Hansson, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Neurology|February 28, 2018
Microangiopathy-A Potential Contributing Factor to Idiopathic Polyneuropathy: A Mini ReviewKristin Samuelsson, Rayomand Press
Lakartidningen|April 21, 2010
[Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far]Rayomand Press, Oluf Andersen
Current Opinion in Neurology|August 11, 2020
Chronic axonal idiopathic polyneuropathy: is it really benignKristin Samuelsson, Rayomand Press
Lakartidningen|June 28, 2012
[Inflammatory polyneuropathies can be treated successfully]Rayomand Press, Håkan Askmark, Oluf Andersen
Journal of the Neurological Sciences|December 3, 2014
Sensory ataxia associated with Graves' diseaseKristin Samuelsson, Mats Palmer, Rayomand Press
Disability and Rehabilitation|November 27, 2008
Disability and health status in patients with chronic inflammatory demyelinating polyneuropathyMimmi Eriksson Westblad, Anette Forsberg, Rayomand Press
Journal of the Neurological Sciences|March 20, 2012
Residual disability 10 years after falling ill in Guillain-Barré syndrome: a prospective follow-up studyAnette Forsberg, Rayomand Press, Lotta Widén Holmqvist
Neurology|February 13, 2002
Non-T(H)1 cytokines are augmented systematically early in Guillain-Barré syndromeRayomand Press, V Ozenci, M Kouwenhoven, et al.
Lakartidningen|March 26, 2025
[Pan-neurofascin autoimmune nodopathy - an emerging and treatable differential diagnosis to Guillain-Barré syndrome]Ivan Kmezic, Anders Eriksson, Eva Sundman, et al.
Journal of the Neurological Sciences|March 6, 2025
Beta-trace protein in chronic inflammatory demyelinating polyradiculoneuropathy and Guillain-Barré syndrome - clinical utilization and a new insight into pathophysiological mechanismsIvan Kmezic, Rasmus Gustafsson, Magnus Hansson, et al.
Pageof 6